Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience
Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Cristina Mussini(University of Modena and Reggio Emilia), Giulia Burastero(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Matteo Faltoni(University of Modena and Reggio Emilia), Mario Sarti(Azienda Ospedaliero-Universitaria di Modena), Giovanni Tassoni(Azienda Ospedaliero-Universitaria di Modena), Shaniko Kaleci(University of Modena and Reggio Emilia), Lucia Serio(University of Modena and Reggio Emilia), Erica Franceschini(University of Modena and Reggio Emilia), Gabriella Orlando(University of Modena and Reggio Emilia), Massimo Girardis(University of Modena and Reggio Emilia), Claudia Venturelli(Azienda Ospedaliero-Universitaria di Modena), Emanuela Biagioni(University of Modena and Reggio Emilia), Elisabetta Bertellini(Azienda Unita' Sanitaria Locale Di Modena), Andrea Bedini(Azienda Ospedaliero-Universitaria di Modena), Gabriele Melegari(Azienda Ospedaliero-Universitaria di Modena)
Cited by 18
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738